Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

SHA:688163 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	188.86	33.28	182.11	150.92	515.73	115.88
Short-Term Investments	-	10.63	9.26	-	-	-
Trading Asset Securities	553.59	764.91	641.21	722.59	417.62	65.15
Cash & Short-Term Investments	742.45	808.82	832.58	873.51	933.35	181.03
Cash Growth	-2.69%	-2.85%	-4.69%	-6.41%	415.59%	53.10%
Accounts Receivable	92.14	46.1	36.68	22.63	7.68	9.59
Other Receivables	1.26	0.9	0.86	0.8	0.98	6.25
Receivables	93.41	47	37.54	23.43	8.66	15.84
Inventory	40.82	43.03	43.28	44.75	54.53	49.18
Prepaid Expenses	-	0.09	0.49	-	-	-
Other Current Assets	24.05	13.22	2.48	7.24	0.51	1.89
Total Current Assets	900.72	912.16	916.36	948.93	997.05	247.93
Property, Plant & Equipment	250.05	200.96	157.34	127.82	117.42	103.67
Long-Term Investments	-	-	-	16.59	17.35	19.81
Other Intangible Assets	22.08	22.47	23.03	23.79	24.24	23.97
Long-Term Deferred Tax Assets	7.6	6.89	8	9.91	9.29	5.09
Long-Term Deferred Charges	0.27	0.39	0.63	0.87	1.11	1.35
Other Long-Term Assets	3.35	14.34	14.66	0.55	0.02	1.06
Total Assets	1,184	1,157	1,120	1,128	1,166	402.89

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	29.34	16.49	1.31	3.64	4.28	2.47
Accrued Expenses	6.61	15.13	14.57	16.92	17.05	11.48
Current Portion of Leases	-	0.77	0.29	0.76	1.37	1.33
Current Income Taxes Payable	11.9	-	-	-	1.51	0.4
Current Unearned Revenue	4.05	3.18	2.2	2.93	1.99	1.44
Other Current Liabilities	3.38	1.33	1.24	0.75	0.68	0.53
Total Current Liabilities	56.02	36.91	19.62	24.99	26.87	17.65
Long-Term Leases	4.14	4.33	4	12.2	12.31	13.02
Long-Term Deferred Tax Liabilities	1.16	1.28	0.91	5.45	5.67	2.59
Other Long-Term Liabilities	2.59	2.04	-	-	-	-
Total Liabilities	63.91	44.55	24.53	42.63	44.86	33.26

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	108.22	108.22	108.22	108.22	108.22	81.16
Additional Paid-In Capital	878.09	878.09	878.09	878.09	871.49	113.62
Retained Earnings	133.86	126.35	109.19	99.53	141.92	174.84
Total Common Equity	1,120	1,113	1,096	1,086	1,122	369.63
Shareholders' Equity	1,120	1,113	1,096	1,086	1,122	369.63
Total Liabilities & Equity	1,184	1,157	1,120	1,128	1,166	402.89

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	4.88	5.1	4.3	12.96	13.68	14.35
Net Cash (Debt)	737.57	803.73	828.28	860.55	919.66	166.68
Net Cash Growth	-2.80%	-2.96%	-3.75%	-6.43%	451.75%	40.97%
Net Cash Per Share	6.90	7.45	7.67	7.99	9.02	2.05
Filing Date Shares Outstanding	159.35	108.22	108.22	108.22	108.22	81.16
Total Common Shares Outstanding	159.35	108.22	108.22	108.22	108.22	81.16
Working Capital	844.7	875.25	896.74	923.94	970.18	230.29
Book Value Per Share	7.03	10.28	10.12	10.03	10.36	4.55
Tangible Book Value	1,098	1,090	1,072	1,062	1,097	345.66
Tangible Book Value Per Share	6.89	10.07	9.91	9.81	10.14	4.26
Buildings	-	127.63	121.51	64.9	60.97	58.87
Machinery	-	79.32	71.64	67.04	62.65	55.95
Construction In Progress	-	80.99	41.84	54.6	43.14	29.52

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 28, 2026

Data Sources Report a data error